The debate over banning or legalizing marijuana has recently been going on for more than a century now, but it continues to be a brand new issue on the table. There are people who strongly support its legalization, while there are many who emphatically oppose it. Nevertheless , over the last decade, the debate has been bent in favour of cannabis as the term “medical marijuana” has gained momentum by making use of legalization campaigns. Still, there are others who are stopping it from going it all legal. cannabidiol info
The conclusions of a recent analyze also go in prefer of optimum medical use of marijuana. It says that the certain chemical found in marijuana can actually help in treating patients with drug-resistant kinds of epilepsy. This new study has provided evidence that pot can be effective in treatment for one-third of epilepsy patients who have a treatment-resistant form of the disease.
The research titled “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” – published in The Lancet Neurology – says that almost one-third of epilepsy patients are treatment-resistant and are associated with severe morbidity and increased death. Though marijuana-based treatments for epilepsy have spiked the interest of those, technological data on the subject matter is very limited, feel the authors.
“We targeted to establish whether addition of cannabidiol to existing anti-epileptic regimens would be safe, tolerated, and effective in children and youngsters with treatment-resistant epilepsy, inch the researchers said.
The researchers, led by Orrin Devinsky, neurologist at New York University Langone The hospital, administered an draw out of 99 percent cannabidiol (CBD) – a non-psychoactive chemical in marijuana – to 162 patients and monitored them for about 12 weeks. The substance was given as a supplement or add-on as well as other preexisting medicines of the patients and was conducted on an open level, this means everyone was aware of what they received. The researchers observed this intervention managed to reduce to motor seizures at the same rate by the existing drugs, but 2 percent of patients became completely seizure free.
In spite of some good success being shown by this method, the researchers feel that there may be need for further comprehensive studies on the subject matter. “Our findings claim that cannabidiol might reduce seizure frequency and might have an satisfactory safety account in children and young adults with highly treatment-resistant epilepsy. Randomized handled studies are warranted to define the safety profile and true efficacy of this compound, ” the examine said.